Sign in

CIK 0001782223

  • Emerging growth company

Pyxis Oncology, Inc.

Sign in to watch
Ticker
PYXS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831160910
Phone
+1 617-221-9059
Business address
321 HARRISON AVENUE, BOSTON, MA, 02118
Open-market buys, last 90 days
$0
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-11-06 HUMPHREY RACHEL Director Grant or award · Stock Option (Right to Buy) +34,500 34,500
2026-10-01 GordonMD Global Investments LP 10% owner Purchase · Common Stock Purchase Warrant +7,172,000 7,172,000
2026-10-01 GordonMD Global Investments LP 10% owner Purchase +5,517,000 15,541,909
2026-10-01 GordonMD Global Investments LP 10% owner Purchase · Common Stock Purchase Warrant +7,546,766 7,546,766
2026-09-04 Civik Thomas CEO & Chairman of the Board Grant or award · Stock Option (Right to Buy) +2,503,050 2,503,050
2026-08-20 Dupont Jakob Director Grant or award · Stock Option (Right to Buy) +46,000 46,000
2026-08-12 Civik Thomas Interim CEO Grant or award · Stock Option (Right to Buy) +250,956 941,087
2026-06-30 Dupont Jakob Director Option exercise 10b5-1 +35,000 $1.60 $56K 73,741
2026-06-30 Dupont Jakob Director Sale 10b5-1 −35,000 $3.06 $107K 38,741
2026-06-30 Dupont Jakob Director Option exercise · Stock Option (Right to Buy) 10b5-1 −35,000 357,461
2026-03-24 Dupont Jakob Director Grant or award · Stock Option (Right to Buy) +45,867 45,867
2026-03-24 Wadhane Jitendra Prin Fin & Acct Officer Grant or award +109,461 512,882
2026-03-24 Wadhane Jitendra Prin Fin & Acct Officer Grant or award · Stock Option (Right to Buy) +262,635 262,635
2026-03-24 FLAVIN JOHN L Director Grant or award · Stock Option (Right to Buy) +45,867 45,867
2026-03-24 Metzger Michael A Director Grant or award · Stock Option (Right to Buy) +45,867 45,867
2026-03-24 Lewis-Hall Freda C Director Grant or award · Stock Option (Right to Buy) +45,867 45,867
2026-03-24 Cline Darren S Director Grant or award · Stock Option (Right to Buy) +45,867 45,867
2026-03-24 HUMPHREY RACHEL Director Grant or award · Stock Option (Right to Buy) +45,867 45,867
2026-03-24 Palani Santhosh Director Grant or award · Stock Option (Right to Buy) +45,867 45,867
2026-02-03 Civik Thomas Interim CEO Grant or award · Stock Option (Right to Buy) +690,131 690,131

Page 1 of 8 · 141 trades